It is important to prevent pancreatic cancer

Pancreatic cancer is one of the common digestive tract malignancies, and is more common in people aged 45 to 65. At present, the high-risk groups for pancreatic cancer are mainly the following: middle-aged and elderly men over 40 years old; patients with non-specific abdominal pain and bloating who have excluded liver, gallbladder, gastrointestinal and other diseases; patients with unexplained weight loss and decreased appetite in a short period of time; those with a family history of cancer, smoking and alcohol abuse; patients with acute or chronic pancreatitis; non-obese diabetic patients with insulin resistance, etc. It is worth noting that pancreatic cancer has a lot to do with lifestyle, especially for high-risk groups, so the key to preventing pancreatic cancer is to develop good living habits.

First of all, we should start by adjusting the dietary structure. For example, we should avoid eating burnt or charred foods, and try to eat less high-fat, high-oil, and high-salt foods, which can reduce the incidence of pancreatic cancer by more than 2/3. In daily diet, we should also pay attention to keeping cereals, beans, sweet potatoes and other coarse grains as the main part of the diet, and fresh vegetables and fruits are essential every day. We should also increase fiber, carotene, vitamin E and necessary minerals in the diet.

Secondly, participate in appropriate physical activities, avoid being overweight and obese, and be sure to control the intake of animal foods and fats such as meat. Reduce social activities, resolutely put an end to overeating, eat a light diet, and don't eat too much.

Third, you need to have a regular life. This is the secret to longevity and the fundamental way to prevent pancreatic cancer.

For the treatment of pancreatic cancer, surgery is currently the only means of radical cure and prolonged survival. Due to the insidious onset of pancreatic cancer, most pancreatic cancer patients are diagnosed in the late stage, and only 10% to 20% of patients are suitable for surgical treatment. In recent years, it has been reported that the postoperative recurrence and metastasis rate is very high, and the 5-year survival rate is <20%, regardless of simple radical surgery or extended radical surgery. It can be seen that simple surgical resection cannot make patients survive for a long time. Therefore, postoperative adjuvant therapy has become the key to improving the survival rate of pancreatic cancer patients. The "2014 Chinese Expert Consensus on Comprehensive Diagnosis and Treatment of Pancreatic Cancer" recommends that postoperative chemotherapy combined with gemcitabine and Segafur Capsules (Weikangda) can significantly improve the prognosis of pancreatic cancer surgery patients. A large number of clinical studies have also confirmed that Segafur Capsules have obvious advantages over other similar drugs for metastatic pancreatic cancer. Whether it is a single drug or combined with other anti-tumor drugs, it has shown obvious advantages in objective response rate, median survival and adverse reactions.

To prevent pancreatic cancer, changing your lifestyle is the key. Please spread the word!